Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.102021207747Produktionsanlage und Verfahren zur Herstellung eines Produkts
DE 26.01.2023
Int.Class A61K 35/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Appl.No 102021207747 Applicant KyooBe Tech GmbH Inventor Bott Mario

Die vorliegende Anmeldung betrifft eine Produktionsanlage (10), insbesondere zur Herstellung von biologisch-pharmazeutischen Produkten (20), und/oder ein Verfahren zur Herstellung eines Produkts (20), insbesondere eines biologisch-pharmazeutischen Produkts (20). embedded image

2.202022106782Antiurolithiatische, antiosteoporotische, antidiabetische und entzündungshemmende Zusammensetzung eines Polykräuterextraktes
DE 26.01.2023
Int.Class A61K 36/59
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
59Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
Appl.No 202022106782 Applicant Azeemuddin Mohammed Inventor

Antiurolithiatische, antiosteoporotische, antidiabetische und entzündungshemmende Polykräuterextrakt-Zusammensetzung, umfassend: a) 100 mg Tinospora sinensis Stamm; b) 150 mg Moringa oleifera-Wurzelrinde; c) 250 mg Acacia sinuata-Schoten; d)Chondroitinsulfat(Standardarzneimittel); e) 0,75 % Ethylenglykol, wobei die Mischung aus wässrigem Extrakt aus Acacia sinuata-Schoten, methanolischem Extrakt aus Moringa oleifera-Wurzelrinde und ethanolischem Extrakt aus Tinospora sinensis-Stämmen im Verhältnis 1:2: 1 besteht und gegen Ethylenglykol-induzierte Urolithiasis, Diabetes, Entzündungen und Osteoporose wirkt, wobei 400mg/kg und 200mg/kg als hohe und niedrige Dosis gewählt wurden.

3.WO/2023/001607MICRONEEDLE ARRAY WITH ANTISEPTICS
WO 26.01.2023
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/EP2022/069218 Applicant LTS LOHMANN THERAPIE-SYSTEME AG Inventor WINTERBERG, Markus
The present invention relates to a microneedle array for use in the intradermal application of active substances, the array comprising a plurality of microneedles on a support which are formed of a formulation that contains a biodegradable polymer, an active substance and an antiseptic.
4.WO/2023/002492CODON OPTIMIZATION OF NUCLEIC ACIDS
WO 26.01.2023
Int.Class A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
Appl.No PCT/IL2022/050794 Applicant YEDA RESEARCH AND DEVELOPMENT CO. LTD. Inventor PILPEL, Yitzhak
A method of codon optimizing the sequence of a nucleic acid encoding a protein of a vaccine, comprising: (a) identifying synonymous codons for an amino acid at a predetermined position of the protein, wherein said predetermined position is a mutation site of a variant of the protein; and (b) selecting the synonymous codon that has a likelihood above a predetermined level to mis-incorporate the mutated amino acid at the predetermined position.
5.WO/2023/002507ECO-FRIENDLY BIOPROCESS FOR SEPARATION OF HEMP PLANT FIBRES FOR VARIOUS APPLICATIONS
WO 26.01.2023
Int.Class A61K 36/60
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
60Moraceae (Mulberry family), e.g. breadfruit or fig
Appl.No PCT/IN2022/050654 Applicant NAMRATA HEMPCO LIMITED Inventor SIRUPA, Harshaavardhan Redi
An eco-friendly bioprocess for separation of hemp plant fibres, from decorticated hemp fibres skin, said process comprising: pre-treating the decorticated hemp fibres skin with an aqueous solution, said aqueous solution bearing a pH in the range of 5.0 to 9.0, wherein said aqueous solution consisting of: 2.0 gm to 5.0 gm of a carbon source per 1 kg of hemp fibre; 1.0 gm to 5.0 gm of a nitrogen source per 1 kg of hemp fibre; biomaterial obtained from a bio-resource material; storing, for natural fermentation, at ambient temperature, in order to separate its fibres, for a time period ranging from 3.0 to 10 days; subsequently, washing the separated fibres with water having a pH in the range of 5.0 to 8.0; and treating the washed and separated fibres with one or more cleaning agent for more cleaner fibres.
6.WO/2023/003122COMPOSITION FOR INHIBITING CORONAVIRUS PROLIFERATION
WO 26.01.2023
Int.Class A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
Appl.No PCT/KR2022/003907 Applicant BEN'S LAB CO., LTD. Inventor JEONG, Jong Moon
The present invention relates to a composition for inhibiting coronavirus proliferation, comprising epigallocatechin gallate (EGCG) as an active ingredient, the composition being applicable locally to the oral cavity, nasal cavity, or the like, thus inhibiting the proliferation of coronavirus that causes respiratory diseases in epithelial cells of the oral cavity, nasal cavity, or the like, and consequently being capable of preventing respiratory diseases or inhibiting the progression of respiratory diseases into the severe stage.
7.WO/2023/003332PLANT-BASED COVID-19 VARIANT RECOMBINANT SPIKE PROTEIN EXPRESSION VECTOR AND RECOMBINANT PROTEIN USING SAME
WO 26.01.2023
Int.Class C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
Appl.No PCT/KR2022/010552 Applicant BIOAPPLICATIONS INC. Inventor SOHN, Eun-Ju
The present invention relates to a plant-based COVID-19 variant recombinant spike protein expression vector, and a recombinant protein using the expression vector, wherein a plant expression system is used such that the recombinant protein does not have the disadvantages of animal-derived recombinant proteins and exhibits an excellent SARS coronavirus 2 prevention and treatment effect, and thus can be effectively utilized as a safe composition for preventing and treating COVID-19.
8.WO/2023/002252COMPOSITION COMPRISING BETA-GLUCANS AND ALPHA-FUCANS FOR IMPROVING GUT HEALTH AND ANIMAL PERFORMANCE AND METHODS OF MAKING THE SAME
WO 26.01.2023
Int.Class A61K 31/716
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716Glucans
Appl.No PCT/IB2022/000421 Applicant BIOATLANTIS LIMITED Inventor O'DOHERTY, John
The present invention relates to a composition and methods comprising an amount of β-glucans and α-fucans, wherein the combination is synergistic to at least one of: increase growth of beneficial microbes and reduced levels of harmful microbes selected from E. coli or Salmonella in animal or human intestines, improve gut structure, reduce gut inflammation, improved nutrient digestibility, improve mineral absorption and growth performance, or reduce gut infection and inflammation.
9.WO/2023/002222COMPOSITIONS COMPRISING DOPED SILICON PARTICLES, AND RELATED METHODS
WO 26.01.2023
Int.Class A61K 8/25
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
19containing inorganic ingredients
25Silicon; Compounds thereof
Appl.No PCT/GB2022/051937 Applicant SISAF LTD Inventor SAFFIE-SIEBERT, Roghieh Suzanne
A pharmaceutical composition comprising particles comprising hydrolysable doped silicon and one or more lipids complexed with an active pharmaceutical ingredient, wherein the particles are doped at a level of at least 1 x1016 dopant atoms per cm3. Also related products, methods, and medical uses.
10.WO/2023/002192AEROSOL GENERATION AND DELIVERY SYSTEM FOR CARBOXYLATED ACTIVES
WO 26.01.2023
Int.Class A24F 40/30
AHUMAN NECESSITIES
24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
FSMOKERS’ REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
40Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
30Devices using two or more structurally separated inhalable precursors, e.g. using two liquid precursors in two cartridges
Appl.No PCT/GB2022/051892 Applicant NICOVENTURES TRADING LIMITED Inventor STROPHAIR, Oriol
The present invention relates to a delivery system comprising a powered aerosol generating device and an aerosolisable material, wherein the powered aerosol generating device comprises a power source and a controller, and the system comprises a first aerosolisable material and a second aerosolisable material, wherein the second aerosolisable material comprises at least one carboxylated active and is stored in the system separately from the first aerosolisable material.